SEC Form 4 · accession 0001562180-18-002718
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C Stump
Director
Period of report
May 25, 2018
Accepted (ET)
May 30, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $49.45 | May 25, 2018 | A | 12,500 | A | — | May 25, 2028 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The option will vest in 12 equal monthly installments following May 25, 2018.